Stroke Trial, Recruiting NCT06166862 Sponsor: Karamanoğlu Mehmetbey University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06166862
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a stroke within the last year
  • People who have some ability to walk, either with help or more independently, based on a walking ability assessment scale (scored 2–5 on the Functional Ambulation Classification)

Who may not be able to join:

  • People who have had more than one stroke
  • People who have a condition called "neglect," where the brain has difficulty paying attention to one side of the body or surroundings after a stroke
  • People who have difficulty thinking or understanding, such as being unable to follow simple spoken instructions
  • People with severe hearing problems
  • People with severe vision problems
  • People with bone, joint, or muscle conditions that affect physical movement, such as amputation, very limited joint movement, or nerve damage in the limbs
  • People with high blood pressure or diabetes that is not well controlled
  • People with a diagnosed lung condition that causes symptoms, such as asthma, chronic obstructive pulmonary disease (COPD), or emphysema
  • People with a diagnosed heart condition that causes symptoms, such as blocked arteries, irregular heartbeat, or heart failure
  • People with reduced blood flow in the arteries of the legs or arms (peripheral artery disease)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yurdagul Bahran Mustu, MD., Karaman Training and Research Hospital

Phone: +90 506 209 76 72

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Karamanoğlu Mehmetbey University
Registry
ClinicalTrials.gov
Start date
12 December 2023
Est. completion
1 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

The difference in the scores of the Fugl-Meyer Assessment between pre- and post-rehabilitation assessments; The difference in the scores of the Brunnstrom stages between pre- and post-rehabilitation assessments

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov